PepGen Ltd (PEPG)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $410.98M
Last updated: Nov 17, 2026 at 11:05 AM ET
PepGen Ltd (PEPG) Earnings: Report Dates and Results
PepGen (PEPG) is expected to report earnings on Mar 2, 2027. In the quarter ended Sep 30, 2026, PepGen reported EPS of -$0.28, below the -$0.27 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
PEPG has an expected report date of Mar 2, 2027.
Earnings History
Of the 19 quarters below that had an estimate, PEPG beat 12 and missed 7. The widest gap in the table came in the quarter ended Mar 31, 2022, when EPS landed 310.85% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.28 | -$0.27 | -$0.29 - -$0.26 | -3.70% | Miss | N/A | 6 | 0 up, 1 down | Nov 10, 2026 |
| Jun 30, 2026 | -$0.26 | -$0.30 | -$0.37 - -$0.26 | +13.33% | Beat | N/A | 7 | 3 up, 1 down | Aug 6, 2026 |
| Mar 31, 2026 | -$0.26 | -$0.35 | -$0.40 - -$0.27 | +26.01% | Beat | N/A | 4 | 2 up, 0 down | May 12, 2026 |
| Dec 31, 2025 | -$0.27 | -$0.39 | -$0.50 - -$0.22 | +30.77% | Beat | N/A | 5 | 3 up, 1 down | Mar 4, 2026 |
| Sep 30, 2025 | -$0.52 | -$0.56 | -$0.72 - -$0.24 | +7.14% | Beat | N/A | 4 | 2 up, 1 down | Nov 12, 2025 |
| Jun 30, 2025 | -$0.70 | -$0.85 | -$0.92 - -$0.71 | +17.65% | Beat | N/A | 2 | 0 up, 0 down | Aug 7, 2025 |
| Mar 31, 2025 | -$0.92 | -$0.75 | -$0.75 - -$0.75 | -22.67% | Miss | N/A | 1 | 0 up, 0 down | May 8, 2025 |
| Dec 31, 2024 | -$0.68 | -$0.81 | -$0.82 - -$0.62 | +16.05% | Beat | N/A | 2 | 1 up, 0 down | Feb 24, 2025 |
| Sep 30, 2024 | -$0.66 | -$0.77 | -$0.98 - -$0.64 | +14.29% | Beat | N/A | 5 | 0 up, 0 down | Nov 7, 2024 |
| Jun 30, 2024 | -$0.87 | -$0.68 | -$0.85 - -$0.66 | -27.94% | Miss | N/A | 5 | 0 up, 0 down | Aug 8, 2024 |
| Mar 31, 2024 | -$0.63 | -$0.64 | -$0.85 - -$0.64 | +1.56% | Beat | N/A | 5 | 0 up, 0 down | May 14, 2024 |
| Dec 31, 2023 | -$0.81 | -$1.01 | -$1.19 - -$0.72 | +19.80% | Beat | N/A | 5 | 0 up, 0 down | Mar 6, 2024 |
| Sep 30, 2023 | -$0.98 | -$0.80 | -$1.06 - -$0.71 | -22.50% | Miss | N/A | 5 | 0 up, 0 down | Nov 8, 2023 |
| Jun 30, 2023 | -$0.82 | -$0.75 | -$0.96 - -$0.71 | -9.33% | Miss | N/A | 5 | 0 up, 0 down | Aug 8, 2023 |
| Mar 31, 2023 | -$0.69 | -$0.74 | -$0.87 - -$0.71 | +6.76% | Beat | N/A | 5 | 0 up, 0 down | May 11, 2023 |
| Dec 31, 2022 | -$0.24 | -$0.87 | -$0.92 - -$0.81 | +72.41% | Beat | N/A | 5 | 0 up, 0 down | Mar 23, 2023 |
| Sep 30, 2022 | -$0.79 | -$1.00 | -$1.39 - -$0.80 | +21.00% | Beat | N/A | 3 | 0 up, 0 down | Nov 10, 2022 |
| Jun 30, 2022 | -$1.23 | -$0.76 | N/A | -61.84% | Miss | N/A | N/A | 0 up, 0 down | Aug 12, 2022 |
| Mar 31, 2022 | -$18.94 | -$4.61 | -$8.33 - -$0.89 | -310.85% | Miss | N/A | 2 | 0 up, 0 down | May 9, 2022 |
| Dec 31, 2021 | -$0.36 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 11, 2022 |
| Sep 30, 2021 | -$0.54 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Oct 1, 2021 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$2.41, after -$2.84 the year before. It was -$0.90 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$2.41 | N/A |
| Dec 31, 2024 | -$2.84 | N/A |
| Dec 31, 2023 | -$3.30 | N/A |
| Dec 31, 2022 | -$21.20 | N/A |
| Dec 31, 2021 | -$0.90 | N/A |
Frequently Asked Questions About PEPG
When is PepGen's next earnings date?
PepGen's next earnings report is expected for Mar 2, 2027.
Did PEPG beat earnings estimates last quarter?
No. PepGen reported EPS of -$0.28 for the quarter ended Sep 30, 2026, below the -$0.27 estimate by 3.70%.
What EPS do analysts expect from PEPG next quarter?
The consensus EPS estimate for PepGen for the quarter ending Dec 31, 2026 is -$0.31 from 10 analysts, with estimates from -$0.55 to -$0.24.
How often does PEPG beat earnings estimates?
PepGen beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +10.57%.
PEPG pages: Overview, Earnings, Forecast, Financials, Competitors